Applying bioinformatics to proteomics: Is machine learning the answer to biomarker discovery for PD and MSA?

Movement Disorders

Volumn 27, Issue 13, 2012, Pages 1595-1597

  Mattison, Hayley A ^a   Stewart, Tessandra ^a   Zhang, Jing ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atypical parkinsonioan disorders (APD); Bioinformatics; Mass spectrometry; Multiple system atrophy (MSA); Parkinson's disease; Proteomics

Indexed keywords

BIOLOGICAL MARKER;

BIOINFORMATICS; COHORT ANALYSIS; HUMAN; MACHINE LEARNING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NOTE; PARKINSON DISEASE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEOMICS; SHY DRAGER SYNDROME;

CEREBROSPINAL FLUID PROTEINS; FEMALE; HUMANS; MALE; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PROTEOMICS;

EID: 84870348120     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25189     Document Type: Note

References (21)

1. Abdi F, Quinn JF, Jankovic J, et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis. 2006; 9: 293-348.
2. Tokuda T, Salem SA, Allsop D, et al. Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease. Biochem Biophys Res Commun. 2006; 349: 162-166.
3. Zhang X, Lu X, Shi Q, et al. Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data. BMC Bioinformatics. 2006; 7: 197.
4. Hong Z, Shi M, Chung KA, et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain. 2010; 133: 713-726.
5. Constantinescu R, Andreasson U, Li S, et al. Proteomic profiling of cerebrospinal fluid in parkinsonian disorders. Parkinsonism Relat Disord. 2010; 16: 545-549.
6. Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, et al. alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol. 2011; 10: 230-240.
7. Shi M, Bradner J, Hancock AM, et al. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol. 2011; 69: 570-580.
8. Shtilbans A, Henchcliffe C. Biomarkers in Parkinson's disease: an update. Curr Opin Neurobiol. 2012; 25: 460-465.
9. Ivosev G, Burton L, Bonner R. Dimensionality reduction and visualization in principal component analysis. Anal Chem. 2008; 80: 4933-4944.
10. Ishigami N, Tokuda T, Ikegawa M, et al. Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy. Mov Disord. 2012; 27: 851-857.
11. Ketterlinus R. Hsieh SY, Teng SH, et al. Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software. Biotechniques. 2005;Suppl: 37-40.
12. Olsson A, Vanderstichele H, Andreasen N, et al. Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem. 2005; 51: 336-345.
13. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol. 2006; 5: 75-86.
14. Wenning GK, Stefanova N. Recent developments in multiple system atrophy. J Neurol. 2009; 256: 1791-808.
15. Shulman JM, De Jager PL, Feany MB. Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol. 2011; 6: 193-222.
16. Alkhalaf A, Zurbig P, Bakker SJ, et al. Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy. PLoS One. 2010; 5: e13421.
17. Saeys Y, Inza I, Larranaga P. A review of feature selection techniques in bioinformatics. Bioinformatics. 2007; 23: 2507-2517.
18. Ulintz PJ, Zhu J, Qin ZS, Andrews PC. Improved classification of mass spectrometry database search results using newer machine learning approaches. Mol Cell Proteomics. 2006; 5: 497-509.
19. Yang ZR, Chou KC. Bio-support vector machines for computational proteomics. Bioinformatics. 2004; 20: 735-741.
20. Zhang J, Sokal I, Peskind ER, et al. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol. 2008; 129: 526-529.
21. Albrethsen J. Reproducibility in protein profiling by MALDI-TOF mass spectrometry. Clin Chem. 2007; 53: 852-858.